Novartis’ wet AMD drug gets FDA filing
The decision is primarily based on Phase III data from the HAWK and HARRIER trials.
Read More
Tag: wet age-related macular degeneration
- Kainova reports positive results for DT‑9081 in advanced solid tumours
- EnteroBiotix completes enrolment for trial of EBX‑102‑02
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
